GIT2 (GIT ArfGAP 2) is a multifunctional signaling protein that serves as a GTPase-activating protein for ADP ribosylation factor family members and plays crucial roles in cellular adhesion, inflammation, and disease pathogenesis 1. The protein functions as a negative regulator of cell motility by suppressing Rac1 and Cdc42-mediated signaling pathways, facilitating translocation of tyrosine phosphatase PTP1B to focal adhesions where it dephosphorylates p130Cas, thereby maintaining cellular adhesion stability 12. GIT2 acts as a repressor of lamellipodial extension and focal adhesion turnover, with its loss sufficient to induce migration in epithelial cells 2. In disease contexts, GIT2 demonstrates complex roles: it protects against inflammatory conditions including necrotizing enterocolitis by modulating MDSC recruitment via NF-κB-CXCL1/CXCL12 pathways 3, and its deficiency attenuates pro-inflammatory responses in human amnion and myometrial cells, potentially offering therapeutic targets for preterm birth prevention 4. Additionally, GIT2 has been implicated in cancer biology, where it promotes ferroptosis resistance in acute myeloid leukemia through alternative splicing mechanisms 5. The protein appears to function as a network coordinator in aging processes and has been associated with inflammatory bowel diseases through genetic variants 67.